Literature DB >> 10962037

Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts.

D W Felsher1, A Zetterberg, J Zhu, T Tlsty, J M Bishop.   

Abstract

Overexpression of the proto-oncogene MYC has been implicated in the genesis of diverse human cancers. One explanation for the role of MYC in tumorigenesis has been that this gene might drive cells inappropriately through the division cycle, leading to the relentless proliferation characteristic of the neoplastic phenotype. Herein, we report that the overexpression of MYC alone cannot sustain the division cycle of normal cells but instead leads to their arrest in G(2). We used an inducible form of the MYC protein to stimulate normal human and rodent fibroblasts. The stimulated cells passed through G(1) and S but arrested in G(2) and frequently became aneuploid, presumably as a result of inappropriate reinitiation of DNA synthesis. Absence of the tumor suppressor gene p53 or its downstream effector p21 reduced the frequency of both G(2) arrest and aneuploidy, apparently by compromising the G(2) checkpoint control. Thus, relaxation of the G(2) checkpoint may be an essential early event in tumorigenesis by MYC. The loss of p53 function seems to be one mechanism by which this relaxation commonly occurs. These findings dramatize how multiple genetic events can collaborate to produce neoplastic cells.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  2000        PMID: 10962037      PMCID: PMC27061          DOI: 10.1073/pnas.190327097

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  myc function and regulation.

Authors:  K B Marcu; S A Bossone; A J Patel
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

Review 2.  Proteins of the Myc network: essential regulators of cell growth and differentiation.

Authors:  M Henriksson; B Lüscher
Journal:  Adv Cancer Res       Date:  1996       Impact factor: 6.242

3.  Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

Authors:  C M Eischen; J D Weber; M F Roussel; C J Sherr; J L Cleveland
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

4.  c-myc and functionally related oncogenes induce both high rates of sister chromatid exchange and abnormal karyotypes in rat fibroblasts.

Authors:  C Cerni; E Mougneau; M Zerlin; M Julius; K B Marcu; F Cuzin
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

5.  c-Myc overexpression associated DHFR gene amplification in hamster, rat, mouse and human cell lines.

Authors:  S Mai; J Hanley-Hyde; M Fluri
Journal:  Oncogene       Date:  1996-01-18       Impact factor: 9.867

6.  A cell cycle study of human mammary epithelial cells.

Authors:  O Larsson; H Blegen; J Wejde; A Zetterberg
Journal:  Cell Biol Int       Date:  1993-06       Impact factor: 3.612

7.  c-Myc overexpression uncouples DNA replication from mitosis.

Authors:  Q Li; C V Dang
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

8.  Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss.

Authors:  K Blyth; A Terry; M O'Hara; E W Baxter; M Campbell; M Stewart; L A Donehower; D E Onions; J C Neil; E R Cameron
Journal:  Oncogene       Date:  1995-05-04       Impact factor: 9.867

9.  Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells.

Authors:  M Eilers; D Picard; K R Yamamoto; J M Bishop
Journal:  Nature       Date:  1989-07-06       Impact factor: 49.962

Review 10.  Oncogenes and cell death.

Authors:  E A Harrington; A Fanidi; G I Evan
Journal:  Curr Opin Genet Dev       Date:  1994-02       Impact factor: 5.578

View more
  61 in total

1.  Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.

Authors:  A L Gartel; X Ye; E Goufman; P Shianov; N Hay; F Najmabadi; A L Tyner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 2.  c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.

Authors:  Chenguang Wang; Yanhong Tai; Michael P Lisanti; D Joshua Liao
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

3.  Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes.

Authors:  Izidore S Lossos; Ash A Alizadeh; Maximilian Diehn; Roger Warnke; Yvonne Thorstenson; Peter J Oefner; Patrick O Brown; David Botstein; Ronald Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

4.  Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression.

Authors:  Asa Karlsson; Debabrita Deb-Basu; Athena Cherry; Stephanie Turner; James Ford; Dean W Felsher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

Review 5.  Cardiac myocyte cell cycle control in development, disease, and regeneration.

Authors:  Preeti Ahuja; Patima Sdek; W Robb MacLellan
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

Review 6.  Facilitating replication under stress: an oncogenic function of MYC?

Authors:  Steffi Herold; Barbara Herkert; Martin Eilers
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

7.  Cdk2 suppresses cellular senescence induced by the c-myc oncogene.

Authors:  Stefano Campaner; Mirko Doni; Per Hydbring; Alessandro Verrecchia; Lucia Bianchi; Domenico Sardella; Thomas Schleker; Daniele Perna; Susanna Tronnersjö; Matilde Murga; Oscar Fernandez-Capetillo; Mariano Barbacid; Lars-Gunnar Larsson; Bruno Amati
Journal:  Nat Cell Biol       Date:  2009-12-13       Impact factor: 28.824

8.  A novel signaling pathway of nitric oxide on transcriptional regulation of mouse kappa opioid receptor gene.

Authors:  Sung Wook Park; Jinhua Li; Horace H Loh; Li-Na Wei
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

9.  MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel.

Authors:  Giuliana Gatti; Giovanna Maresca; Manuela Natoli; Fulvio Florenzano; Angelo Nicolin; Armando Felsani; Igea D'Agnano
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

10.  c-myc and N-myc promote active stem cell metabolism and cycling as architects of the developing brain.

Authors:  Alice Wey; Paul S Knoepfler
Journal:  Oncotarget       Date:  2010-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.